Last Updated on August 18, 2021 by The Health Master
Mesalamine extended-release capsules are indicated for the maintenance of remission of ulcerative colitis in adults.
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad.
The group now has 320 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.
For informative videos by The Health Master, click on the below YouTube icon: